ArticleBMC bioinformatics2025
Scmaskgan: masked multi-scale CNN and attention-enhanced GAN for scRNA-seq dropout imputation.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- scZiva: imputation method for single-cell RNA-seq data with zero-inflated variational autoencoder.BMC bioinformatics · 2026Article
- Prior-guided factorization for reliable imputation of scRNA-seq data.PLoS computational biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Single-cell RNA sequencing (scRNA-seq) enables high-resolution analysis of cellular heterogeneity, but dropout events, where gene expression is undetected in individual cells, present a significant challenge. We propose scMASKGAN, which transforms matrix imputation into a pixel restoration task to improve the recovery of missing gene expression data. Specifically, we integrate masking, convolutional neural networks (CNNs), attention mechanisms, and residual networks (ResNets) to effectively address dropout events in scRNA-seq data. The masking mechanism ensures the preservation of complete cellular information, while convolution and attention mechanisms are employed to capture both global and local features. Residual networks augment feature representation and effectively mitigate the risk of model overfitting. Additionally, cell-type labels are incorporated as constraints to guide the methods in learning more accurate cellular features. Finally, multiple experiments were conducted to evaluate the methods' performance using seven different data types and scRNA-seq data from ten neuroblastoma samples. The results demonstrate that the data imputed by scMASKGAN not only perform excellently across various evaluation metrics but also significantly enhance the effectiveness of downstream analyses, enabling a more comprehensive exploration of underlying biological information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.